Transforming Drug Discovery and Wellness Through AI-Powered Scientific Prompt Generation: A White Paper on Swalife Biotech\u27s Discovery Suite

The convergence of artificial intelligence (AI) and life sciences is redefining the landscape of drug discovery and preventive healthcare. AI-powered scientific prompt generation has emerged as a novel approach to accelerating research workflows, enhancing hypothesis development, and supporting data-driven decision-making. This white paper presents Swalife Biotech’s Discovery Suite, an integrated AI-driven platform designed to transform drug discovery and wellness innovation through intelligent prompt engineering tailored to scientific and biomedical applications. By leveraging domain-specific knowledge, machine learning models, and structured scientific reasoning, the Discovery Suite enables efficient target identification, lead optimization, and wellness solution development. The platform supports multidisciplinary research by bridging computational intelligence with biological insight, reducing development timelines, and improving translational relevance. This approach highlights the growing role of AI-assisted scientific creativity in advancing therapeutic discovery and personalized wellness strategies

Transforming Ocular Toxicity Assessment Through AI: A White Paper on the ICE Test Analysis Tool

Ocular toxicity assessment is a critical component of safety evaluation for pharmaceuticals, chemicals, and consumer products. The Isolated Chicken Eye (ICE) test is a widely accepted alternative method for identifying severe eye irritants, offering ethical and scientific advantages over traditional in vivo testing. Recent advances in artificial intelligence (AI) have opened new opportunities to enhance the accuracy, consistency, and efficiency of ICE test analysis. This white paper explores the integration of AI-driven analytical frameworks into ocular toxicity assessment, focusing on automated data interpretation, image-based scoring, and predictive modeling. By reducing subjectivity and improving reproducibility, AI-supported ICE test analysis has the potential to strengthen decision-making, accelerate safety evaluations, and support regulatory acceptance. The convergence of AI and alternative toxicity testing represents a transformative step toward more reliable, ethical, and data-driven ocular safety assessment

Immunological Memory in Viral Infections: Lessons from COVID-19

Immunological memory is basically the immune system’s way of not starting from scratch every time it sees a virus. Once the body has gone through that first encounter, the next one is usually quicker and more effective-though how well this works can depend a lot on the virus itself. B cells and T cells are the central players here, but over the past few years scientists have noticed that even some innate immune cells can be “trained” to respond a little better the second time. The strength and the durability of this memory, however, are uneven. Some viruses, like measles, give protection that pretty much lasts a lifetime. Others, such as the seasonal coronaviruses, don’t leave much of a lasting impression at all, which is why people can keep catching them. COVID-19 came along and forced researchers to study these differences in real time. Both infection and vaccination against SARS-CoV-2 create a layered form of immune memory-antibodies at first, but also memory B cells and T cells that stick around. The antibody levels fade within a few months, but the cellular memory seems to last longer and has been especially important in preventing serious disease. Vaccination, especially with the mRNA platforms, has turned out to be very effective in building this long-term memory. And when people have both infection and vaccination- so-called hybrid immunity- the protection is broader and more durable than either alone. That said, the story isn’t finished. People respond differently depending on age and health, the virus itself keeps mutating, and the current vaccines don’t really boost mucosal immunity in the respiratory tract. Understanding all of this in the context of COVID-19 doesn’t just help with today’s vaccine strategies- it also gives clues for how we might handle whatever virus shows up next

Targeted Drug Delivery Systems in Oncology: A Review of Recent Patents and future directions

Cancer remains a global health challenge, necessitating innovative treatment strategies to improve outcomes while minimizing side effects. Targeted Drug Delivery Systems (TDDS) have revolutionized oncology by addressing limitations of traditional chemotherapy, such as systemic toxicity, lack of specificity, and drug resistance. Utilizing nanotechnology, biomarker-based targeting, and immunotherapy, TDDS enables precise drug delivery to tumors, enhancing efficacy while protecting healthy tissues. Nanotechnology has facilitated the development of liposomes, dendrimers, micelles, and solid lipid nanoparticles, leveraging the Enhanced Permeability and Retention (EPR) effect for tumor accumulation. Examples like Doxil, a PEGylated liposomal doxorubicin, have improved ovarian cancer treatment by reducing cardiotoxicity. Biomarker-based approaches, such as antibody-drug conjugates (ADCs), further enhance specificity. Trastuzumab emtansine (Kadcyla), targeting HER2-positive breast cancer, has demonstrated improved survival rates. TDDS also integrates with immunotherapy to boost immune checkpoint inhibitors, enhance antigen delivery, and optimize cytokine therapy. Lipid nanoparticles and dendrimers are being engineered to improve immune responses while minimizing adverse effects. However, challenges such as tumor heterogeneity, drug resistance, high production costs, and regulatory barriers limit widespread adoption. Ongoing research focuses on overcoming these barriers through personalized medicine, AI-driven designs, and sustainable platforms. TDDS represents a paradigm shift in oncology, combining precision and safety to improve patient outcomes. By integrating emerging technologies and addressing current limitations, TDDS holds the potential to transform cancer treatment, offering hope for better survival and quality of life

Deciphering Anxiety with Zebrafish: A Versatile Model for Anxiolytic Studies

Background - Studies on behavioral pharmacology are increasingly using zebrafish as model organisms. Numerous anxiety-related behaviors in zebrafish have been documented, yet little is known about how anxiolytic drugs impact these behaviors. Anxiety is currently one of the primary unmet medical needs. Despite the wide variety of anxiolytic drugs available, many patients either do not respond well to current pharmacotherapy or see a lessening of their reactivity with repeated treatment. Search for novel compounds and learn how anxiolytic drugs function. Main body of the abstract - In the first task, we concurrently looked at the adult zebrafish\u27s motility, color, height in the tank, and cohesiveness of the shoal. We examine the effects of buspirone hydrochloride, ethanol, benzodiazepines, and a common anxiolytic drug used in medical facilities for humans. Anxiolysis\u27s symptoms were not brought on by anxiolytic drugs, which work by agonisting GABA receptors. We search for anxiolytic drugs in two genetically distinct populations of zebrafish, and the results show that the light/dark preference test is a sensitive, practical, and cost-effective technique. Two important behavioral characteristics seem to be shoal cohesion and tank height among the various groups of these treatments. Conclusion - The findings show that measuring the effects of human anxiolytic medications may be done simply and sensitively using zebrafish behavior

Community Engagement Strategies in Enhancing General Social Services

Background: Community engagement is increasingly recognized as a vital approach in strengthening general social services by ensuring inclusivity, equity, and sustainability. Methodology: This review synthesizes theoretical models, historical evolution, and practical frameworks of community engagement, examining strategies such as public dialogue, participatory planning, co-creation, educational outreach, digital engagement, and participatory research. Both needsbased and strengths-based approaches were considered to highlight their roles in service design and delivery. Results: Evidence indicates that effective engagement improves trust, social capital, cultural relevance, and accountability in service provision. Engagement levels ranging from community-oriented to community-owned models demonstrate varying impacts, with deeper community involvement fostering empowerment, resilience, and sustainable change. Success factors include tailoring approaches to context, building trust, empowering marginalized groups, and fostering collaborative partnerships. Conclusion: Community engagement is a transformative process in general social services, shifting the paradigm from top-down delivery to inclusive, communitydriven models. By prioritizing local voices and co-ownership, engagement strategies enhance service responsiveness, promote social justice, and create sustainable pathways for improved social outcomes

Technology Integration in Nursing Science

Background: Nursing science, traditionally grounded in compassionate and holistic care, is undergoing a transformative shift through technology integration. Advances in electronic health records (EHRs), artificial intelligence (AI), robotics, telehealth, and simulation-based education have redefined clinical practice, education, and research. This evolution addresses critical gaps in traditional nursing practice, such as fragmented communication, manual documentation errors, and delayed clinical decision-making. Methodology: This review critically examined literature, historical developments, and current applications of technology in nursing, synthesizing evidence across clinical, educational, and research domains. The analysis focused on technological tools, implementation challenges, and their impact on patient care, professional development, and system efficiency. Results: Findings indicate that technology enhances patient safety, improves workflow efficiency, supports predictive analytics, and strengthens nursing education through simulation and immersive learning. AI and wearable devices enable personalized and proactive care, while telehealth expands access in underserved populations. However, barriers such as high costs, digital literacy gaps, workflow disruptions, resistance to change, and cybersecurity concerns persist. Ethical implications—especially regarding AI and patient data—remain central to responsible integration. Conclusion: Technology integration has become indispensable in nursing science, enabling precision, efficiency, and global connectivity while preserving nursing’s foundational values of compassion and advocacy. Overcoming financial, infrastructural, and ethical challenges will require sustained leadership, inclusive training, and robust policy frameworks. Future directions point toward precision nursing, AI-driven care, robotics, and smart hospital ecosystems, ensuring equitable access and advancing nursing science worldwide

Mesalamine Microemulsions for Crohn’s Disease: A Review

oai:ojs.ijhse.com:article/1This analysis delves into the promise of mesalamineencapsulated microemulsions in improving bioavailability and therapeutic effectiveness for Crohn\u27s disease. Crohn’s disease, a persistent inflammatory condition of the bowel, frequently necessitates precise medication administration owing to the particular sites of inflammation found in the gastrointestinal system. Mesalamine, a commonly utilised treatment, exhibits restricted efficacy owing to its inadequate absorption in the upper gastrointestinal tract and swift metabolic breakdown. This manuscript explores the obstacles linked to conventional mesalamine formulations and investigates the latest innovations in microemulsion-driven delivery mechanisms aimed at enhancing drug solubility, stability, and precise targeting. Innovative microemulsion methodologies, such as pH-sensitive and enzymeresponsive frameworks, exhibit potential in overcoming the shortcomings of current therapies, creating opportunities for more efficient and patient-centric treatment alternatives

Integration of Evidence-Based Practice in Nursing Science

Background: Evidence-Based Practice (EBP) is essential in modern nursing for improving patient outcomes, enhancing quality of care, and ensuring safety. Despite its proven benefits, adoption remains inconsistent across healthcare settings due to barriers such as lack of training, limited resources, and resistance to change. Understanding these challenges and identifying effective strategies are critical for integrating EBP into routine nursing practice. Methodology: This review synthesizes findings from scientific literature, policy documents, and clinical implementation studies. It evaluates educational interventions, organizational frameworks, and technological tools that support EBP adoption. Key strategies assessed include leadership support, mentorship programs, continuing professional development, and digital platforms facilitating access to clinical guidelines and research evidence. Results: Evidence shows that structured training programs, interdisciplinary collaboration, and leadership engagement significantly increase nurses’ confidence and use of EBP. Digital innovations such as online evidence repositories, AI-driven clinical decision support tools, and mobile health applications further strengthen implementation. However, persistent barriers include time constraints, inadequate staffing, limited funding, and organizational cultures resistant to change. Conclusion: Integrating EBP into nursing requires a multipronged approach that combines leadership commitment, staff empowerment, continuous education, and supportive technologies. Sustainable adoption depends on aligning institutional policies with evidence-based standards and fostering a culture that values inquiry and innovation. Future directions include embedding AI-driven decision tools, strengthening mentorship models, and expanding international collaborations to create a resilient and globally unified evidence-based nursing workforce

Impact of Electronic Health Records and Automation on Pharmaceutical Management Efficiency: A Narrative Review

The integration of Electronic Health Records (EHRs) and automation in pharmaceutical management has significantly improved medication safety, inventory control, and workflow efficiency. EHRs facilitate realtime access to patient data, enabling healthcare providers to make informed decisions while reducing prescription errors and ensuring adherence to treatment protocols. Automation technologies, including computerized physician order entry (CPOE), robotic dispensing systems, and artificial intelligence (AI)-driven inventory management, have optimized pharmaceutical supply chains, minimized wastage, and enhanced medication dispensing accuracy. However, challenges such as interoperability issues, cybersecurity threats, high implementation costs, and resistance to technological adoption hinder the full potential of these advancements. Addressing these challenges requires the development of standardized data-sharing protocols, regulatory frameworks for AIdriven decision-making, and enhanced cybersecurity measures. Future advancements in AI, blockchain technology, and predictive analytics hold promise for further improving pharmaceutical management. This review explores the impact of EHRs and automation on pharmaceutical efficiency, highlighting both the benefits and limitations of these technologies while discussing strategies for their effective implementation in modern healthcare systems